A randomized, open-label, crossover, drug interaction study to evaluate the effects of DVS SR [desvenlafaxine sustained release] and duloxetine on the pharmacokinetics of desipramine in healthy subjects
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2008
At a glance
- Drugs Desipramine; Desvenlafaxine; Duloxetine
- Indications Generalised anxiety disorder; Major depressive disorder; Pain; Stress incontinence; Vasomotor symptoms
- Focus Pharmacokinetics
- Sponsors Wyeth
- 01 Dec 2008 Results were published in Drug Metabolism and Disposition.
- 05 Dec 2007 Results have been presented at the International Forum on Mood and Anxiety Disorders 2007 (1101137)
- 25 May 2007 Status changed from planning to completed.